Research
Hormonal
Exercise-induced vascular remodeling (angiogenesis and arteriogenesis) improves organ blood flow and can compensate for occluded arteries, particularly in patients with cardiovascular disease.
Regular exercise helps grow new blood vessels and enlarge existing ones, improving blood flow to organs and helping the body compensate for blocked arteries.
GoodSupportsHIGH confidence
These changes of the architecture of the vascular tree are likely associated with functional changes and improved organ blood flow... This process appears to be more important for the outcome of cardiovascular patients than the growth of new capillaries.
Why this rating
Supported by animal and human studies cited.
Source
Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy?
Georg Kojda et al. · Cardiovascular Research · 2005
DOI 10.1016/j.cardiores.2005.04.032
narrative_reviewCited 359×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Regular exercise training acts as an effective antioxidant therapy by upregulating vascular eNOS and antioxidant enzymes (SOD1, SOD3) while downregulating pro-oxidant enzymes (NAD(P)H oxidase), thereby improving endothelial function and reducing cardiovascular risk.Good
- The vascular benefits of exercise, specifically eNOS upregulation, are transient and depend on baseline activity levels; sedentary individuals see significant gains, while active individuals see minimal changes.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →